Brief: Somalogic Issued Statement In Response To Press Release By Madryn Asset Management
27/12/2023 10:44
Dec 27 (Reuters) - Standard BioTools Inc LAB.O :
* ISSUED STATEMENT IN RESPONSE TO A PRESS RELEASE ISSUED BY
MADRYN
ASSET MANAGEMENT
* SINCE ANNOUNCEMENT OF PENDING MERGER WITH STANDARD
BIOTOOLS, NOT
RECEIVED INDICATION OF INTEREST OR PROPOSAL FROM LABCORP,ANY
OTHER PARTY
* TRANSACTION WITH STANDARD BIOTOOLS IS RESULT OF A
THOROUGH,
INDEPENDENT AND DELIBERATIVE BOARD PROCESS
* BELIEVES THAT TRANSACTION WITH STANDARD BIOTOOLS IS BEST
PATH
FORWARD FOR CO AND ITS STOCKHOLDERS
* URGES ALL STOCKHOLDERS TO VOTE "FOR" TRANSACTION WITH
STANDARD
BIOTOOLS
* SOMALOGIC STOCKHOLDERS ARE ADVISED TO DISCARD ANY GREEN
PROXY
CARDS THEY RECEIVE FROM MADRYN
Source text for Eikon: ID:nPn4pS9GJa
Further company coverage: LAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Somalogic
See all newsBrief: Somalogic Stockholders Vote To Approve Standard Biotools Transaction At Special Meeting
Brief: Madryn Asset Management Demands Somalogic’S Board Address Repeated, Unprecedented Adjournments Of Tainted Special Meeting
Brief: Madryn Asset Management Says It Urges All Somalogic Shareholders To Oppose Transaction With Standard Biotools
Brief: Madryn Asset Management Urges Shareholders To Vote “Against” The Proposed Merger And Allow Somalogic To Pursue Value-Enhancing Alternatives
Brief: Somalogic Board Reiterates Value-Maximizing Transaction With Standard Biotools Is In Best Interests Of All Stockholders